Comparative Study of Changes in Metabolites Before and After Modified Electroconvulsive Therapy

Exploratory Study on Changes in Blood and Brain Metabolites Before and After Modified Electroconvulsive Therapy - Exploratory Study on Changes in Metabolites Before and After mECT

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000050601

Enrollment

Registered

2023-03-20

Start date

2023-03-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

schizophrenia, major depression, bipolar disorder, catatonia

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Persons undergoing ECT for the purpose of treating depression, bipolar disorder, schizophrenia, or catatonia.

Exclusion criteria

Exclusion criteria: People with physical diseases that affect blood metabolites, such as kidney or liver disorders.

Design outcomes

Primary

Measure	Time frame
Blood metabolites and brain metabolites.	—

Secondary

Measure	Time frame
PANSS, HAM-D, MMSE, HDS-R, GAF, DIEPSS, ECT dose, fMRI, NIRS	—

Countries

Japan

Contacts

Public ContactKazuhiro Suzuki

Shinshu University Department of Community Mental Health

kazsuzuki@shinshu-u.ac.jp0263372638

Outcome results